San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

Researchers have identified a key weakness in acute myeloid leukemia ... rapid progression and resistance to existing ...

What Do Your Blood Cells Do?Leukemia develops in the blood cells produced by your bone marrow. These include: Red blood cells (RBCs), which deliver oxygen throughout the bodyWhite blood cells (WBCs), ...

Autolus Therapeutics said it received Food and Drug Administration approval of its treatment of acute lymphoblastic leukemia, or ALL, an aggressive blood and bone marrow cancer, for certain patients.

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

Kyle Owens needs a bone-marrow transplant, and he and his family are hoping people between the ages of 18-40 will take a cheek swab test to see if they're a match.

Army Spc. Nicholas Filtz has the heart of a warrior as he faces a battle with cancer. Last year, he was diagnosed with a rare cancer called Acute Lymphoblastic Leukemia, which is a common childhood ...

A second-round draft choice from Alabama in 2022, wide receiver John Metchie III scored his first NFL touchdown on Sunday ...

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

AUCATZYL® (obecabtagene autoleucel) approved by US FDA on November 8, ahead of target PDUFA date of November 16; US commercial launch initiatedBLA approval triggers $30m milestone payment to Autolus ...